GlassScriptPhysician profile
Salah E Aboubakr
NPI 1235249772
$13,180.69
in general payments reported to CMS, 2019-2025
35 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $624 · 2021: $942 · 2022: $1,481 · 2023: $1,216 · 2024: $6,443 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301 · Education: $4,000 · Travel and Lodging: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,301.20 |
| Education | $4,000.00 |
| Travel and Lodging | $991.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,079.51 | 2023-2024 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,282.35 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $1,045.14 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $999.27 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $860.71 | 2019-2024 | Yupelri |
| Insmed, INC. | $347.50 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $324.74 | 2019-2025 | Incourage Airway Clearance Therapy, (Ak6) Vest Therapy |
| Amgen INC. | $222.26 | 2024-2025 | Tezspire |
| Harmony Biosciences LLC | $205.18 | 2020-2023 | Wakix |
| Viatris Specialty LLC | $178.84 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $173.09 | 2021-2024 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $164.79 | 2020-2025 | Glassia |
| Inspire Medical Systems, INC. | $153.08 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $146.41 | 2022-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $118.40 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $117.74 | 2024-2025 | |
| Electromed, INC. | $114.22 | 2023-2025 | Smartvest |
| United Therapeutics Corporation | $86.79 | 2024-2025 | Tyvaso, Tyvaso |
| Axsome Therapeutics, INC. | $80.68 | 2023-2024 | Sunosi |
| Grifols USA, LLC | $77.42 | 2019-2022 | |
| Verona Pharma, INC. | $57.71 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $41.41 | 2020-2022 | |
| Resmed Corp | $40.41 | 2019-2020 | |
| Penumbra, INC. | $31.80 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $29.65 | 2019-2025 | Opsumit, Uptravi |
| Shire North American Group INC | $28.31 | 2019 | |
| Pulmonx Corporation | $28.26 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Advanced Respiratory, INC | $25.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.26 | 2021 | |
| Ani Pharmaceuticals, INC. | $23.36 | 2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $18.32 | 2022 | |
| La Jolla Pharmaceutical Company | $14.83 | 2025 | Giapreza |
| Teva Pharmaceuticals USA, INC. | $13.30 | 2023 | Airduo Digihaler |
| Melinta Therapeutics, LLC | $12.84 | 2022 | |
| Circassia INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salah Aboubakr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.